Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
This study has been completed.
Study NCT00262405 Information provided by University of Michigan
First Received on September 12, 2005. Last Updated on March 5, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Idiopathic Pulmonary Fibrosis
Additional conditions recognized in this trial
Fibrosis
Pulmonary Fibrosis
More general conditions related to this trial
Idiopathic Interstitial Pneumonias
Lung Diseases
Lung Diseases, Interstitial
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
zileuton
azathioprine/prednisone
Additional drug interventions recognized in this trial
Azathioprine
Prednisone
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Central Nervous System Agents
Enzyme Inhibitors
Glucocorticoids
Hormone Antagonists
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Leukotriene Antagonists
Lipoxygenase Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of Michigan
National Institutes of Health (NIH)
Back to top of Main Content
